ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that mAbxience will equip its state-of-the-art cGMP facility in León, Spain with an ABEC 4.000 liter CSR bioreactor. The system will come into operation in mid-2021 and will significantly increase the manufacturing capacity of biosimilars and CDMO at the León plant.

READ MORE